查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1586067

大麻药品市场：按品牌、产品类型、适应症、分销管道 - 全球预测 2025-2030

Cannabis Pharmaceuticals Market by Brand (Epidiolex, Sativex), Product Type (Ointments & Creams, Solids and Dissolvable Powder & Oil), Indication, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年大麻药品市场价值为14.4亿美元，预计2024年将达到17.1亿美元，复合年增长率为18.75%，到2030年将达到48.2亿美元。

大麻医药市场包括源自大麻化合物的医药级产品的研究、开发和商业化，主要是大麻二酚（CBD）和四氢大麻酚（THC）等大麻素。人们越来越多地接受大麻衍生药物来治疗癫痫、慢性疼痛、多发性硬化症和癌症相关疾病，从而推动了该领域的发展。大麻药物的需求源于其比传统药物具有治疗功效且副作用更少的承诺。应用包括疼痛管理、神经病学、肿瘤学和安宁疗，最终用户包括医院、诊所、製药公司和研究机构。关键的成长要素包括合法化程度的提高、消费者意识的提高以及证明大麻治疗有效性的持续研究。此外，在扩大监管核准、开发新型输送系统以及利用与生物技术产业的协同效应效应方面也存在潜在机会。然而，市场面临监管障碍、地区接受度不同、研究成本高等限制。智慧财产权挑战和供应链问题使这些障碍更加复杂。此外，社会偏见和严格临床试验的要求是阻碍市场扩张的主要挑战。为了充分利用成长机会，公司应专注于创新，例如先进的萃取技术、精密配方方法和针对特定基因谱和条件的个人化医疗方法。将人工智慧和资料分析整合到研究中可以深入了解患者反应的变化并优化产品开发平臺。总体而言，市场呈现出动态的特点，以快速的技术进步和不断变化的法律制度为特征，为相关人员创造了机会和挑战。透过与研究机构建立强有力的合作并倡导更清晰的监管环境，您可以增加成长前景并更顺利地驾驭不断变化的环境。

主要市场统计
基准年[2023] 14.4亿美元
预测年份 [2024] 17.1亿美元
预测年份 [2030] 48.2亿美元
复合年增长率（%） 18.75%

市场动态：揭示快速发展的大麻药品市场的关键市场洞察

供需的动态交互作用正在改变大麻药品市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 全球药用大麻合法化程度不断提高
    • 人们越来越认识到大麻二酚的医疗益处及其治疗特性
    • 越来越多地使用大麻为基础的药物来治疗发炎、慢性疼痛和睡眠障碍等各种适应症
  • 市场限制因素
    • 与医用大麻相关的高价格
  • 市场机会
    • 增加对大麻药物的投资
    • 扩大线上和零售药局的供应范围
  • 市场挑战
    • 多个国家对大麻萃取物合法化有严格规定

波特的五力：驾驭大麻医药市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解大麻药品市场的外部影响

外部宏观环境因素在塑造大麻药品市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解大麻药品市场的竞争格局

对大麻製药市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，以应对日益激烈的竞争。

FPNV 大麻药品市场定位矩阵供应商绩效评估

FPNV 定位矩阵是评估大麻製药市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议为大麻药品市场的成功指明了道路

大麻製药市场的策略分析对于旨在加强其在全球市场的影响力的公司至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界各地医用大麻合法化程度不断提高
      • 人们越来越认识到大麻二酚的医疗益处及其治疗特性
      • 以大麻为基础的药物越来越多地用于治疗发炎、慢性疼痛和睡眠障碍等各种适应症。
    • 抑制因素
      • 医用大麻价格高
    • 机会
      • 增加对大麻药物的投资
      • 透过线上和零售药局增加可用性
    • 任务
      • 一些国家对大麻萃取物。
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章以品牌分類的大麻药品市场

  • Epidiolex
  • 萨蒂克斯

第七章 大麻药品市场：依产品类型

  • 软膏和霜
  • 固态、可溶性粉末和油

第八章以适应症分類的大麻药品市场

  • 关节炎
  • 癌症
  • 癫痫
  • 偏头痛

第九章 大麻药品市场：按分销管道

  • 医院药房
  • 网路药房
  • 零售药房

第10章美洲大麻药品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太大麻药品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的大麻药品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Aphria, Inc.
  • Aurora Cannabis, Inc.
  • Bausch Health Companies, Inc.
  • Botanix Pharmaceuticals
  • Breath of Life Pharma, Ltd.
  • Cannabis Science, Inc.
  • Cannamedical Pharma GmbH
  • Canopy Growth Corporation
  • Cara Therapeutics Inc.
  • CB Therapeutics Inc.
  • Celadon Pharmaceuticals PLC
  • Corbus Pharmaceuticals Holdings, Inc.
  • Cronos Group Inc. By Altria Group
  • Green Thumb Industries
  • Jazz Pharmaceuticals PLC
  • Medical Marijuana Inc.
  • MGC Pharmaceuticals Limited
  • Panaxia Pharmaceutical Industries
  • Pascal Biosciences Inc.
  • PharmaCyte Biotech, Inc.
  • Renew Biopharma, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Tilray Brands, Inc.
  • Zynerba Pharmaceuticals, Inc. by Harmony Biosciences
Product Code: MRR-221461476B43

The Cannabis Pharmaceuticals Market was valued at USD 1.44 billion in 2023, expected to reach USD 1.71 billion in 2024, and is projected to grow at a CAGR of 18.75%, to USD 4.82 billion by 2030.

The cannabis pharmaceuticals market encompasses the research, development, and commercialization of pharmaceutical-grade products derived from cannabis compounds, primarily cannabinoids like cannabidiol (CBD) and tetrahydrocannabinol (THC). This sector is driven by the growing acceptance of cannabis-derived medications for treating conditions such as epilepsy, chronic pain, multiple sclerosis, and cancer-related symptoms. The necessity for cannabis pharmaceuticals arises from their potential to offer therapeutic benefits with fewer side effects compared to traditional pharmaceuticals. The application scope spans across pain management, neurology, oncology, and palliative care, with end-users including hospitals, clinics, pharmaceutical companies, and research institutes. Key growth factors include increasing legalization, consumer awareness, and ongoing research substantiating the efficacy of cannabis-based treatments. Additionally, potential opportunities lie in expanding regulatory approvals, developing novel delivery systems, and leveraging synergies with the biotechnology industry. However, the market faces limitations such as regulatory hurdles, varying regional acceptance, and high research costs. Intellectual property challenges and supply chain issues further compound these barriers. Furthermore, societal stigma and stringent clinical trial demands create significant challenges that hinder market expansion. To capitalize on growth, businesses should focus on innovations such as advanced extraction techniques, precise formulation methods, and personalized medicine approaches that cater to specific genetic profiles and conditions. The integration of AI and data analytics in research can offer insights into patient response variability and optimize product development pipelines. Overall, the market exhibits a dynamic nature, characterized by rapid advancements in technology and fluctuating legislative landscapes, presenting both opportunities and challenges for stakeholders. Establishing strong collaborations with research institutions and advocating for clearer regulatory frameworks can enhance growth prospects and facilitate smoother navigation through the evolving cannabis pharmaceuticals landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 1.44 billion
Estimated Year [2024] USD 1.71 billion
Forecast Year [2030] USD 4.82 billion
CAGR (%) 18.75%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cannabis Pharmaceuticals Market

The Cannabis Pharmaceuticals Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the legalization of medicinal cannabis worldwide
    • Growing awareness about the medical benefits of cannabidiol and its remedial properties
    • Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, and sleep disorders
  • Market Restraints
    • High prices associated with medical cannabis
  • Market Opportunities
    • Rise in investments in cannabis-based pharmaceuticals
    • Growing availability through online and retail pharmacies
  • Market Challenges
    • Strict regulations in legalization of cannabis extract in several countries

Porter's Five Forces: A Strategic Tool for Navigating the Cannabis Pharmaceuticals Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cannabis Pharmaceuticals Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cannabis Pharmaceuticals Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cannabis Pharmaceuticals Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cannabis Pharmaceuticals Market

A detailed market share analysis in the Cannabis Pharmaceuticals Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cannabis Pharmaceuticals Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cannabis Pharmaceuticals Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cannabis Pharmaceuticals Market

A strategic analysis of the Cannabis Pharmaceuticals Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cannabis Pharmaceuticals Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Aphria, Inc., Aurora Cannabis, Inc., Bausch Health Companies, Inc., Botanix Pharmaceuticals, Breath of Life Pharma, Ltd., Cannabis Science, Inc., Cannamedical Pharma GmbH, Canopy Growth Corporation, Cara Therapeutics Inc., CB Therapeutics Inc., Celadon Pharmaceuticals PLC, Corbus Pharmaceuticals Holdings, Inc., Cronos Group Inc. By Altria Group, Green Thumb Industries, Jazz Pharmaceuticals PLC, Medical Marijuana Inc., MGC Pharmaceuticals Limited, Panaxia Pharmaceutical Industries, Pascal Biosciences Inc., PharmaCyte Biotech, Inc., Renew Biopharma, Inc., Teva Pharmaceutical Industries Ltd., Tilray Brands, Inc., and Zynerba Pharmaceuticals, Inc. by Harmony Biosciences.

Market Segmentation & Coverage

This research report categorizes the Cannabis Pharmaceuticals Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Brand, market is studied across Epidiolex and Sativex.
  • Based on Product Type, market is studied across Ointments & Creams and Solids and Dissolvable Powder & Oil.
  • Based on Indication, market is studied across Arthritis, Cancer, Epilepsy, and Migraine.
  • Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the legalization of medicinal cannabis worldwide
      • 5.1.1.2. Growing awareness about the medical benefits of cannabidiol and its remedial properties
      • 5.1.1.3. Growing usage of cannabis-based pharmaceuticals for various indications such as inflammation, chronic pain, and sleep disorders
    • 5.1.2. Restraints
      • 5.1.2.1. High prices associated with medical cannabis
    • 5.1.3. Opportunities
      • 5.1.3.1. Rise in investments in cannabis-based pharmaceuticals
      • 5.1.3.2. Growing availability through online and retail pharmacies
    • 5.1.4. Challenges
      • 5.1.4.1. Strict regulations in legalization of cannabis extract in several countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cannabis Pharmaceuticals Market, by Brand

  • 6.1. Introduction
  • 6.2. Epidiolex
  • 6.3. Sativex

7. Cannabis Pharmaceuticals Market, by Product Type

  • 7.1. Introduction
  • 7.2. Ointments & Creams
  • 7.3. Solids and Dissolvable Powder & Oil

8. Cannabis Pharmaceuticals Market, by Indication

  • 8.1. Introduction
  • 8.2. Arthritis
  • 8.3. Cancer
  • 8.4. Epilepsy
  • 8.5. Migraine

9. Cannabis Pharmaceuticals Market, by Distribution Channel

  • 9.1. Introduction
  • 9.2. Hospital Pharmacies
  • 9.3. Online Pharmacies
  • 9.4. Retail Pharmacies

10. Americas Cannabis Pharmaceuticals Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Cannabis Pharmaceuticals Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Cannabis Pharmaceuticals Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Aphria, Inc.
  • 3. Aurora Cannabis, Inc.
  • 4. Bausch Health Companies, Inc.
  • 5. Botanix Pharmaceuticals
  • 6. Breath of Life Pharma, Ltd.
  • 7. Cannabis Science, Inc.
  • 8. Cannamedical Pharma GmbH
  • 9. Canopy Growth Corporation
  • 10. Cara Therapeutics Inc.
  • 11. CB Therapeutics Inc.
  • 12. Celadon Pharmaceuticals PLC
  • 13. Corbus Pharmaceuticals Holdings, Inc.
  • 14. Cronos Group Inc. By Altria Group
  • 15. Green Thumb Industries
  • 16. Jazz Pharmaceuticals PLC
  • 17. Medical Marijuana Inc.
  • 18. MGC Pharmaceuticals Limited
  • 19. Panaxia Pharmaceutical Industries
  • 20. Pascal Biosciences Inc.
  • 21. PharmaCyte Biotech, Inc.
  • 22. Renew Biopharma, Inc.
  • 23. Teva Pharmaceutical Industries Ltd.
  • 24. Tilray Brands, Inc.
  • 25. Zynerba Pharmaceuticals, Inc. by Harmony Biosciences

LIST OF FIGURES

  • FIGURE 1. CANNABIS PHARMACEUTICALS MARKET RESEARCH PROCESS
  • FIGURE 2. CANNABIS PHARMACEUTICALS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CANNABIS PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CANNABIS PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CANNABIS PHARMACEUTICALS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CANNABIS PHARMACEUTICALS MARKET DYNAMICS
  • TABLE 7. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPIDIOLEX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SATIVEX, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY OINTMENTS & CREAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY SOLIDS AND DISSOLVABLE POWDER & OIL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY EPILEPSY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY MIGRAINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CANNABIS PHARMACEUTICALS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 35. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 39. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 53. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 61. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 65. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 73. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 77. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 89. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 93. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 106. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 110. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 114. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 122. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 126. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 134. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 138. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 146. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 150. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 158. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 162. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 166. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 170. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 174. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 178. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY BRAND, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM CANNABIS PHARMACEUTICALS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 190. CANNABIS PHARMACEUTICALS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 191. CANNABIS PHARMACEUTICALS MARKET, FPNV POSITIONING MATRIX, 2023